Alcresta
Alcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases.
Funding reportedLast round: Undisclosed round
Follow Alcresta and see its new rounds in your feed.Start following
What company datasets say Alcresta raised
Funding, as reported
Reported in all139.4Min the source's currency
Rounds5
Last roundUndisclosed round
Last round dateFeb 2020
Investors listed4
Founders and team
From Alcresta's own website: 8 on the team.
- Daniel OrlandoChief Executive Officer
- Bill ScheinlerChief Legal and Compliance Officer and Secretary
- Chris ArnoldChief Commercial Officer
- Chris ParrishChief Operating Officer
- Ian VawterChief Financial Officer
- Jason WeinerChief Strategy and Business Development Officer
- Greta LoringVP, Research and New Product Development
- Jim KevilVP, Finance
On 2 portfolio pages
Investors who name them
Each firm lists Alcresta on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Alcresta in front of investors. Or tell us what we have wrong.